SCHEMBL5319219

SCHEMBL5319219

CCCCCCCCCC(=O)OCCCl

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.77
DNM1 Q05193 1/20 0.62
PAM P19021 2/20 0.58
TSHR P16473 1/20 0.55
MAPT P10636 1/20 0.55
PRSS1 P07477 1/20 0.54
PRSS2 P07478 1/20 0.54
PRSS3 P35030 1/20 0.54
NAAA Q02083 1/20 0.53
LMNA P02545 4/20 0.53
ALDH1A1 P00352 1/20 0.53
KDM4E B2RXH2 1/20 0.51
DUSP3 P51452 1/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
HTR2C P28335 1/20 0.51
PRKCA P17252 1/20 0.49
PRKCE Q02156 1/20 0.49
PRKCQ Q04759 1/20 0.49
PRKCD Q05655 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4362110 1.00 DGKA (0.77) DGKADNM1PAMTSHRMAPT
SCHEMBL10430876 1.00 DGKA (0.77) DGKADNM1PAMTSHRMAPT
SCHEMBL14760960 1.00 DGKA (0.77) DGKADNM1PAMTSHRMAPT
SCHEMBL5318935 1.00 DGKA (0.77) DGKADNM1PAMTSHRMAPT
SCHEMBL11794989 1.00 DGKA (0.77) DGKADNM1PAMTSHRMAPT
SCHEMBL9948675 1.00 DGKA (0.77) DGKADNM1PAMTSHRMAPT
SCHEMBL11785899 0.98 DGKA (0.73) DGKADNM1PAMTSHRMAPT
Dimethylamine SCHEMBL20566068 0.94 DGKA (0.69) DGKADNM1PAMTSHRMAPT
SCHEMBL11791883 0.92 DGKA (0.63) DGKADNM1PAMTSHRMAPT
SCHEMBL11782881 0.90 DGKA (0.62) DGKAMAPTLMNAALDH1A1DUSP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114058173-A Process and composition for producing flexible polyurethane foams 赢创运营有限公司 2022-02-18 CN claimed
WO-2007079252-A2 SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS AMPHASTAR PHARMACEUTICALS, INC. (US) 2007-07-12 WO disclosed
US-20070154546-A1 Sustained release pharmaceutical compositions INTERNATIONAL MEDICATION SYSTEMS, LIMITED 2007-07-05 US disclosed
US-3970678-A Organotin mercaptide process CINCINNATI MILACRON CHEMICALS, INC. (US) 1976-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070154546-A1 Sustained release pharmaceutical compositions PLA2G2C, PLTP, F12 DGKA 3455/4885DNM1 4131/4885PAM 288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.